XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Statements of Comprehensive Loss [Abstract]    
Sales $ 1,206,218 $ 1,179,689
Cost of sales 441,938 370,384
Gross margin 764,280 809,305
Operating expenses:    
Research and development 5,813,755 4,084,304
Sales and marketing 558,852 208,735
General and administrative 5,430,704 4,262,002
Depreciation and amortization 561,233 591,068
Total operating expenses 12,364,544 9,146,109
Loss from operations (11,600,264) (8,336,804)
Other income (expense):    
Interest income, net 228,164 3,768
Other income 0 821,515
Interest expense (13,464) (19,226)
Other expense (2,306) (3,098)
Total other income 212,394 802,959
Loss before income taxes (11,387,870) (7,533,845)
Income tax expense 6,300 4,000
Net loss (11,394,170) (7,537,845)
Net loss attributable to common stockholders, basic (11,394,170) (7,537,845)
Net loss attributable to common stockholders, diluted $ (11,394,170) $ (7,537,845)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.96) $ (1.12)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.96) $ (1.12)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 11,815,019 6,712,028
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 11,815,019 6,712,028